Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

MDxHealth (MDXH) Receivables - Other (2020 - 2023)

MDxHealth has reported Receivables - Other over the past 4 years, most recently at $36000.0 for Q4 2023.

  • For Q4 2023, Receivables - Other fell 99.62% year-over-year to $36000.0; the TTM value through Dec 2023 reached $36000.0, down 99.62%, while the annual FY2023 figure was $36000.0, 99.62% down from the prior year.
  • Receivables - Other was $36000.0 for Q4 2023 at MDxHealth, down from $9.4 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $9.4 million in Q4 2022 and bottomed at $36000.0 in Q4 2023.
  • The 4-year median for Receivables - Other is $4.2 million (2020), against an average of $4.4 million.
  • Year-over-year, Receivables - Other surged 104.21% in 2022 and then crashed 99.62% in 2023.
  • Over 4 years, Receivables - Other stood at $3.8 million in 2020, then rose by 21.51% to $4.6 million in 2021, then surged by 104.21% to $9.4 million in 2022, then crashed by 99.62% to $36000.0 in 2023.
  • The last three reported values for Receivables - Other were $36000.0 (Q4 2023), $9.4 million (Q4 2022), and $4.6 million (Q4 2021) per Business Quant data.